Llwytho...
Bad Company: Microenvironmentally Mediated Resistance to Targeted Therapy in Melanoma
This review will focus on the role of the tumor microenvironment (TME) in the development of drug resistance in melanoma. Resistance to mitogen-activated protein kinase inhibitors (MAPKi) in melanoma is observed months after treatment, a phenomenon that is often attributed to the incredible plastici...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Pigment Cell Melanoma Res |
|---|---|
| Prif Awduron: | , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2018
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6727967/ https://ncbi.nlm.nih.gov/pubmed/30216694 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/pcmr.12736 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|